Alvogen, Inc FDA Inspection Record

FEI 3008454186 · Inspections, Form 483s, warning letters and import refusals

Alvogen, Inc is an FDA-inspected facility (FEI 3008454186) located in Morristown, NJ, US. RegDataLab tracks 5 FDA inspections at this facility.

What FDA found at this site

Latest inspection
Nov 21, 2024: No Action Indicated (NAI)
Inspections on record
5 (2 VAI, 3 NAI)
Last OAI inspection
None on record
Warning letters
None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
Recalls as the recalling firm
10, latest Dec 31, 2025
Import refusals
2

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Nov 21, 2024No Action Indicated (NAI)No citations listed
Jun 10, 2021Voluntary Action Indicated (VAI)Failure to comply with REMS Implementation System (FDCA 505-1(f)(4))
Sep 11, 2020Voluntary Action Indicated (VAI)Failure to develop written procedures (21 CFR 314.80(b))
Late submission of 15-day report (21 CFR 314.80(c)(1)(i))
Interval (21 CFR 314.80(c)(2))
Jan 18, 2017No Action Indicated (NAI)No citations listed
May 20, 2011No Action Indicated (NAI)No citations listed

Recalls

Newest first. Recalls FDA's Enforcement Report lists with this FEI as the recalling firm. The recalling firm is not always the site that made the product. Search FDA's Enforcement Report by recall number.

DateClassRecallProduct and reason
Dec 31, 2025Class IID-0259-2026Levothyroxine Sodium Tablets, USP, Thyro-Tabs, 150mcg, 1000 Tablets, Rx only, Manufactured…
Product Mix-Up: A single bottle of this lot was reported by a pharmacy to contain 88 mcg tablets instead of 150 mcg tablets.
Jan 31, 2025Class ID-0245-2025Fentanyl Transdermal System CII, 25mcg/h, packaged in a pouch, further packaged in 5-count…
Defective delivery system - patches could be multi-stacked, adhered one on top of the other, in a single product pouch.
Feb 6, 2023Class IID-0353-2023Levothyroxine Sodium Tablets, USP 112 mcg, 90 tablets per bottle, Rx Only, Manufactured by…
Sub-Potent Drug: Out of specification for assay at the 24 month interval.
Feb 26, 2021Class IID-0649-2021Buprenorphine and Naloxone Sublingual Film 2mg/0.5mg, 30 pouches each containing 1…
Subpotent drug: Out of specification for assay of naloxone and buprenorphine (low)
Jul 24, 2019Class IID-1722-2019Nitrofurantoin Monohydrate/Macrycrystals Capsules, 100 mg, 100-count bottle, Rx Only… and 1 more product
Failed dissolution specifications
Apr 19, 2019Class ID-1277-2019FENTANYL Transdermal System, 12 mcg/h, five (12 mcg/h) systems per carton, Rx only…
Product Mix-Up: Customer complaint that their carton labeled as Fentanyl Transdermal Systems, 12 mcg/h contained five patches labeled and…
Jun 16, 2017Class IID-0939-2017Clindamycin Injection USP; 300 mg/2 mL (150 mg/mL). 2 mL Single-dose ADD-VANTAGE Vial, Rx… and 2 more products
Lack of Assurance of Sterility
Mar 7, 2017Class IIID-0627-2017Nifedipine Extended-Release Tablets, 30 mg, 100-count bottles, Rx Only, Manufactured for… and 8 more products
Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib
Apr 21, 2015Class IID-1082-2015NITROFURANTOIN MONOHYDRATE/MACROCRYSTALS CAPSULES, 100 mg, 100 count bottle, Rx Only…
Failed Dissolution Specification; 6 month time point
Aug 28, 2014Class IID-1607-2014Oxycodone and Acetaminophen Tablets USP 10 mg/325 mg 100 count bottles Rx Only…
Failed Content Uniformity Specifications - The lot failed to meet the acceptance criteria for Uniformity of Dosage Units at the time of…

FDA record score

31 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.

Counted on Nov 16, 2026, method version 1. It counts records and does not judge the site: a low number does not establish that a site is safe, and sites that FDA inspects more often can collect more points. How this is counted.

11 records behind this number
RecordDatePoints x age weightAdds
Class I recall D-0245-2025, this FEI as the recalling firmJan 31, 202515 x 115
Class II recall D-0259-2026, this FEI as the recalling firmDec 31, 20254 x 14
Class I recall D-1277-2019, this FEI as the recalling firmApr 19, 201915 x 0.253.8
Class II recall D-0353-2023, this FEI as the recalling firmFeb 6, 20234 x 0.62.4
Inspection classified VAIJun 10, 20216 x 0.251.5
Inspection classified VAISep 11, 20206 x 0.251.5
Class II recall D-0649-2021, this FEI as the recalling firmFeb 26, 20214 x 0.251
Class II recall D-1722-2019, this FEI as the recalling firmJul 24, 20194 x 0.251
Class II recall D-0939-2017, this FEI as the recalling firmJun 16, 20174 x 0.251
Class II recall D-1082-2015, this FEI as the recalling firmApr 21, 201510 years or older, so it adds no points0
Class II recall D-1607-2014, this FEI as the recalling firmAug 28, 201410 years or older, so it adds no points0

When each source was last refreshed

FDA sources behind this page and when RegDataLab last refreshed each one
RecordsLast refreshedSource as ofStatus
InspectionsNov 16, 2026Newest record Nov 5, 2026Current
Inspection citationsNov 16, 2026Newest record Nov 5, 2026Current
Compliance actions (warning letters, injunctions and other action types)Nov 2, 2026Newest record Oct 29, 2026Current
Warning letter textNov 16, 2026Newest record Nov 10, 2026Current
Recalls (Enforcement Report)Nov 16, 2026Newest record Nov 11, 2026Current
Form 483s and inspection documentsNov 13, 2026Newest record Nov 12, 2026Current
Import refusalsNov 15, 2026Newest record Nov 5, 2026Current

Reviewing Alvogen, Inc as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Alvogen, Inc yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Facility details

Company
Alvogen, Inc
Location
Morristown, NJ (US)
Source
inspections

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.